Decreased Cardiac Autonomic Function is Associated with Higher Exacerbation Risk and Symptom Burden in Chronic Obstructive Pulmonary Disease
Sarath Raju, MD, MPH1 Han Woo, PhD1 Ashraf Fawzy, MD, MPH1 Nirupama Putcha, MD, MHS1 Aparna Balasubramanian, MD, MHS1 Stephen C. Mathai1 Ronald D. Berger, MD, PhD1 Nadia N. Hansel, MD, MPH1,2 Meredith C. McCormack, MD, MHS1,2
Citation: Raju S, Woo H, Fawzy A, et al. Decreased cardiac autonomic function is associated with higher exacerbation risk and symptom burden in chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2023; Published online June 2, 2023. doi: https://doi.org/10.15326/jcopdf.2023.0410
Associations of Smoking, Cytomegalovirus Serostatus, and Natural Killer Cell Phenotypes in Smokers With and At Risk for COPD
Robert M. Burkes1,2 Elijah Bailey1, Timothy Hwalek1, Andrew Osterburg1, Laura Lach2, Ralph Panos2, Stephen N. Waggoner3,4, Michael T. Borchers1,2
Citation: Burkes RM, Bailey E, Hwalek T, et al. Associations of smoking, cytomegalovirus serostatus, and natural killer cell phenotypes in smokers with and at risk for COPD. Chronic Obstr Pulm Dis. 2023; Published online June 2, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0382
Clinical Use of an Exposure, Symptom, and Spirometry Algorithm to Stratify Smokers into COPD Risk Phenotypes: A Case Finding Study Combined with Smoking Cessation Counseling
Abraham Bohadana1 Ariel Rokach1 Pascal Wild, PhD2 Ofir Kotek3 Chen-Chen Shuali1 Hava Azulai1and Gabriel Izbicki1
Citation: Bohadana A, Rokach, Wild AP, et al. Clinical use of an exposure, symptom, and spirometry algorithm to stratify smokers into COPD risk phenotypes: a case finding study combined with smoking cessation counseling. Chronic Obstr Pulm Dis. 2023; Published online May 18, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0368
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History
Manuel Izquierdo, DO1 Chad R Marion, DO, PhD1 Frank Genese, DO2 John D. Newell, MD3 Wanda K. O'Neal, PhD4 Xingnan Li, PhD5 Gregory A. Hawkins, PhD6 Igor Barjaktarevic MD, PhD7 R. Graham Barr MD, PhD8 Stephanie Christenson, MD9 Christopher B. Cooper, MD, PhD7 David Couper, PhD10 Jeffrey Curtis MD11,12 Meilan K. Han MD, MS12 Nadia N. Hansel MD, MPH13 Richard E. Kanner, MD14 Fernando J. Martinez, MD, MS15 Robert Paine, III, MD14 Vickram Tejwani MD16 Prescott G. Woodruff, MD, MPH9 Joe G. Zein MD, PhD16 Eric A. Hoffman PhD3 Stephen P. Peters MD, PhD1 Deborah A. Meyers PhD5 Eugene R. Bleecker, MD5 Victor E. Ortega, MD, PhD17 for the National Heart, Lung and Blood Institute’s SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) investigators
Citation: Izquierdo M, Marion CR, Genese F, et al; for the National Heart, Lung and Blood Institute’s SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) investigators. Impact of bronchiectasis on COPD severity and alpha-1 antitrypsin deficiency as a risk factor in individuals with a heavy smoking history. Chronic Obstr Pulm Dis. 2023; Published online May 16, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0388
Changes in Lung Volumes with Spirometric Disease Progression in COPD
Mehrdad Arjomandi, MD 1,2, Siyang Zeng, MS 1,3, Jianhong Chen, MS 1,2, Surya P Bhatt, MD 4, Fereidoun Abtin, MD 5, Igor Barjaktarevic, MD, PhD 5, R Graham Barr, MD, PhD 6, Eugene R Bleecker, MD 7, Russell G. Buhr, MD, PhD 5, Gerard J Criner, MD 8, Alejandro P Comellas, MD 9, David J Couper, PhD 10, Jeffrey L Curtis, MD 11, Mark T Dransfield, MD 4, Spyridon Fortis, MD 9, MeiLan K Han, MD, MS 10, Nadia N Hansel, MD, MPH 12, Eric A Hoffman, PhD 9, John E Hokanson, MPH, PhD 13, Robert J Kaner, MD 14, Richard E Kanner, MD 15, Jerry A Krishnan, MD, PhD 16, Wassim Labaki, MD 10, David A Lynch, MD 17, Victor E Ortega, MD, PhD 18, Stephen P Peters, MD, PhD 19, Prescott G Woodruff, MD 2, MPH, the COPDGene and SPIROMICS Investigators, Christopher B Cooper, MD 5, Russell P Bowler, MD, PhD, 20 Robert Paine III, MD 15, PhD 20, Stephen I Rennard, MD 21, Donald P Tashkin, MD 6
Citation: Arjomandi M, Zeng S, Chen J, et al. Changes in lung volumes with spirometric disease progression in COPD. Chronic Obstr Pulm Dis. 2023; Published online May 16, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0363
Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons
Igor Barjaktarevic, MD, PhD,1 Christopher B. Cooper, MD,1 Tracie Shing, DrPH,2 Russell G. Buhr, MD, PhD,1,3 Eric A. Hoffman, PhD,4 Prescott G. Woodruff, MD, MPH,5 M. Bradley Drummond, MD, MHS6, Richard E. Kanner, MD,7 MeiLan K. Han, MD, MS,8 Nadia N. Hansel, MD9, Russell P. Bowler, MD, PhD,10 Gregory L. Kinney, MPH, PhD,11, Sean Jacobson, MS,11 Madeline A. Morris, MPH,12 Fernando J. Martinez, MD, MS,13 Jill Ohar, MD,14 David Couper, PhD,2 Donald P. Tashkin, MD1
Citation: Barjaktarevic I, Cooper CB, Shing T, et al. Impact of marijuana smoking on COPD progression in a cohort of middle-aged and older persons. Chronic Obstr Pulm Dis. 2023; Published online May 16, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0378
Understanding the Patient Experience of Home-Based Pulmonary Rehabilitation With Health Coaching for COPD: A Qualitative Interview Study
William R. Midthun, BA1 Maria V. Benzo, MD1 Jennifer L. Ridgeway, PhD2,3 Roberto P. Benzo, MD, MS1
Citation: Midthun WR, Benzo MV, Ridgeway JL, Benzo RP. Understanding the patient experience of home-based pulmonary rehabilitation with health coaching for COPD: a qualitative interview study. Chronic Obstr Pulm Dis. 2023; Published online May 3, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0384
The Experiences of Individuals With a History of Acute Exacerbations of COPD and Their Thoughts on Death: Empirical Qualitative Research
Yasemin Ceyhan, PhD, RN1
Citation: Ceyhan Y. The experiences of individuals with a history of acute exacerbations of COPD and their thoughts on death: empirical qualitative research. Chronic Obstr Pulm Dis. 2023; Published online May 3, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0389
Impact of COVID-19 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD
Eva Pappe, MD1, Ralf Hammerich, MD2, Jacopo Saccomanno, MD1, Thomas Sgarbossa1, Anne Pohrt, PhD3, Bernd Schmidt, MD4, Christian Grah, MD5, Stephan Eisenmann, MD6, Angelique Holland, MD7, Stephan Eggeling, MD8, Franz Stanzel, MD9, Martin Witzenrath, MD1, Ralf-Harto Hübner, MD1
Citation: Pappe E, Hammerich R, Saccomanno J, et al. Impact of COVID-19 on hospital admissions, health status, and behavioral changes of patients with COPD. Chronic Obstr Pulm Dis. 2023; Published online May 3, 2023. doi: https://doi.org/10.15326/jcopdf.2022.0383